Search

everythinglearnresearchcommunity

for

Search:↓

Deleting the CD271 gene in mouse skin cells leads to disorganized skin and increased hair growth, suggesting CD271 is important for skin health.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

Clascoterone may be an effective topical treatment for hair loss.

LGR5 helps maintain corneal cell characteristics and prevents unwanted changes by controlling specific cell signaling pathways.

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

ADCs can effectively treat breast cancer but may cause side effects like nausea and hair loss.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Cyclosporin A helps mice grow hair by blocking a specific protein activity in skin cells.

CD146 + mesenchymal stem cells are more effective for treating premature ovarian failure.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Nε-(carboxymethyl) lysine delays hair growth by blocking a key protein.

Li2CO3 improved skin disease in a mouse model of Focal Dermal Hypoplasia without toxicity.

Claudin-1 is crucial for maintaining skin barrier and preventing inflammation.

Lack of functional CYLD in mice leads to early aging and cancer.

COVID-19 vaccination may trigger recurrence of cutaneous T-cell lymphoma in some patients.

Blocking S100A8 can reduce chemotherapy-induced hair loss.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

Cepharanthine helps reduce cell aging caused by the cancer drug Doxorubicin by boosting cell cleanup processes.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

Albumin and prednisone improved symptoms in a woman with Cronkhite-Canada syndrome, revealing potential genetic causes.

Skin cells can naturally limit the growth of cancerous changes by balancing cell renewal and differentiation.

Inhibiting ornithine decarboxylase may help prevent certain skin cancers.

SIG-1451 could be a promising new treatment for atopic dermatitis.

The A allele of the C2 gene increases the risk of lupus, while the G allele may protect against it.

Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.